141 related articles for article (PubMed ID: 36189960)
1. Unraveiling the correlation among neurodevelopmental and inflammatory biomarkers in patients with chronic schizophrenia.
Nani JV; Almeida PGC; Noto C; Bressan RA; Brietzke E; Hayashi MAF
Nord J Psychiatry; 2022 Oct; 76(7):559-564. PubMed ID: 36189960
[TBL] [Abstract][Full Text] [Related]
2. Plasma Ndel1 enzyme activity is reduced in patients with schizophrenia--a potential biomarker?
Gadelha A; Machado MF; Yonamine CM; Sato JR; Juliano MA; Oliveira V; Bressan RA; Hayashi MA
J Psychiatr Res; 2013 May; 47(5):657-63. PubMed ID: 23388542
[TBL] [Abstract][Full Text] [Related]
3. Protein-Protein and Peptide-Protein Interactions of NudE-Like 1 (Ndel1): A Protein Involved in Schizophrenia.
Hayashi MA; Felicori LF; Fresqui MA; Yonamine CM
Curr Protein Pept Sci; 2015; 16(8):754-67. PubMed ID: 25961396
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of NDEL1 oligopeptidase activity in blood and brain in an animal model of schizophrenia: effects of psychostimulants and antipsychotics.
Nani JV; Lee RS; Yonamine CM; Sant'Anna OA; Juliano MA; Gadelha A; Mari JJ; Hayashi MAF
Sci Rep; 2020 Oct; 10(1):18513. PubMed ID: 33116174
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide investigation of schizophrenia associated plasma Ndel1 enzyme activity.
Gadelha A; Coleman J; Breen G; Mazzoti DR; Yonamine CM; Pellegrino R; Ota VK; Belangero SI; Glessner J; Sleiman P; Hakonarson H; Hayashi MA; Bressan RA
Schizophr Res; 2016 Apr; 172(1-3):60-7. PubMed ID: 26851141
[TBL] [Abstract][Full Text] [Related]
6. Interaction of BDNF and cytokines in executive dysfunction in patients with chronic schizophrenia.
Xiu MH; Wang DM; Du XD; Chen N; Tan SP; Tan YL; Yang F; Cho RY; Zhang XY
Psychoneuroendocrinology; 2019 Oct; 108():110-117. PubMed ID: 31255950
[TBL] [Abstract][Full Text] [Related]
7. Ndel1 oligopeptidase activity as a potential biomarker of early stages of schizophrenia.
Dal Mas C; Nani JV; Noto C; Yonamine CM; da Cunha GR; Mansur RB; Ota VK; Belangero SI; Cordeiro Q; Kapczinski F; Brietzke E; Bressan RA; Gadelha A; Hayashi MAF
Schizophr Res; 2019 Jun; 208():202-208. PubMed ID: 30857875
[TBL] [Abstract][Full Text] [Related]
8. Interaction of BDNF with cytokines in chronic schizophrenia.
Zhang XY; Tan YL; Chen DC; Tan SP; Yang FD; Wu HE; Zunta-Soares GB; Huang XF; Kosten TR; Soares JC
Brain Behav Immun; 2016 Jan; 51():169-175. PubMed ID: 26407757
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptides and oligopeptidases in schizophrenia.
Rodríguez B; Nani JV; Almeida PGC; Brietzke E; Lee RS; Hayashi MAF
Neurosci Biobehav Rev; 2020 Jan; 108():679-693. PubMed ID: 31794779
[TBL] [Abstract][Full Text] [Related]
10. Identification of an ex vivo inhibitor of the schizophrenia biomarker Ndel1 by high throughput screening.
Nani JV; Coelho C; Oyadomari WY; Santiago TC; Machado MM; Christoff RR; Garcez PP; Oliveira V; Würtele M; Hayashi MAF
Biochem Pharmacol; 2023 Nov; 217():115841. PubMed ID: 37820964
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of IL-1Ra are associated with schizophrenia.
Zhou Y; Peng W; Wang J; Zhou W; Zhou Y; Ying B
Psychiatry Clin Neurosci; 2019 Mar; 73(3):109-115. PubMed ID: 30375100
[TBL] [Abstract][Full Text] [Related]
12. Oligopeptidases activity in bipolar disorder: Ndel1 and angiotensin I converting enzyme.
Dal Mas C; Carvalho MS; Marins LA; Yonamine CM; Cordeiro Q; McIntyre RS; Mansur RB; Brietzke E; Hayashi MAF
J Affect Disord; 2019 Feb; 244():67-70. PubMed ID: 30321766
[TBL] [Abstract][Full Text] [Related]
13. Sodium nitroprusside as an adjunctive treatment for schizophrenia reduces the Ndel1 oligopeptidase activity.
Nani JV; Ushirohira JM; Bradshaw NJ; Machado-de-Sousa JP; Hallak JEC; Hayashi MAF
Braz J Psychiatry; 2023 Nov; ():. PubMed ID: 37994832
[TBL] [Abstract][Full Text] [Related]
14. [Establishment of diagnostic model for schizophrenia based on neurotrophic factor and other biomarkers].
Pang LJ; Li X; Yuan XX; Hei GR; Zhang LY; Wang SY; Chen YS; Song PL; Song XQ
Zhonghua Yi Xue Za Zhi; 2023 May; 103(17):1310-1315. PubMed ID: 37150680
[No Abstract] [Full Text] [Related]
15. Angiotensin converting enzyme activity is positively associated with IL-17a levels in patients with schizophrenia.
Gadelha A; Yonamine CM; Nering M; Rizzo LB; Noto C; Cogo-Moreira H; Teixeira AL; Bressan R; Maes M; Brietzke E; Hayashi MA
Psychiatry Res; 2015 Oct; 229(3):702-7. PubMed ID: 26296754
[TBL] [Abstract][Full Text] [Related]
16. Radix Bupleuri aqueous extract attenuates MK801-induced schizophrenia-like symptoms in mice: Participation of intestinal flora.
Yang P; Huang S; Luo Z; Zhou S; Zhang C; Zhu Y; Yang J; Li L
Biomed Pharmacother; 2024 Mar; 172():116267. PubMed ID: 38364739
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory and neurotrophic factor plasma levels are related to epilepsy independently of etiology.
Alvim MKM; Morita-Sherman ME; Yasuda CL; Rocha NP; Vieira ÉL; Pimentel-Silva LR; Henrique Nogueira M; Barbosa R; Watanabe N; Coan AC; Lopes-Cendes I; Teixeira AL; Cendes F
Epilepsia; 2021 Oct; 62(10):2385-2394. PubMed ID: 34331458
[TBL] [Abstract][Full Text] [Related]
18. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
[TBL] [Abstract][Full Text] [Related]
20. BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis.
Huang E; Hettige NC; Zai G; Tomasi J; Huang J; Zai CC; Pivac N; Nikolac Perkovic M; Tiwari AK; Kennedy JL
Pharmacogenomics J; 2019 Jun; 19(3):269-276. PubMed ID: 30181602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
